Abstract: Systems and methods for video processing generates 3D streaming data via an API may be provided. A 3D streaming session may be delivered at a client device with low latency and high throughput capacity. Upon verification of the client device, a server may be selected to support an encapsulated 3D streaming engine to initiate the session. A library file may be injected into an executable file of the encapsulated 3D streaming engine to generate a digital representation of an interactive 3D environment. The interactive 3D environment may be rendered, encoded, and streamed to the client device via a GPU. The 3D streaming session may be adjusted via the client device, and sustained until terminated at the client device. A number of virtual compute instances of encapsulated 3D streaming engines provided by the server may be dynamically adjusted based on metrics and machine learning predictions of connected client devices.

Abstract: The invention relates to an apparatus for determining and/or monitoring a temperature of a medium in a containment, comprising a measuring insert having a temperature sensor for registering temperature, a protective tube, in which the temperature sensor is arranged, and a heat conductive, formed piece, which is arranged in the protective tube and surrounds the measuring insert at least sectionally.

Abstract: The invention relates to a device for optical applications, which has an optical waveguide (10), to which a light source (11) can be connected. The optical waveguide (10) is designed in such a way that light emitted by the connectable light source (11) propagates along a light propagation axis (12). A wavelength-sensitive grating structure (13) in the optical waveguide (10) has detectors (20), which are arranged in such a way that the detectors absorb partial amounts of the light of the light source (11) that is scattered by the wavelength-sensitive grating structure (13). The grating structure (13) in the optical waveguide (10) is constructed of periodically arranged ellipsoid structural elements (14). The ellipsoid structural elements (14) have a different index of refraction than the material of the optical waveguide (10) surrounding the ellipsoid structural elements.

Abstract: The present invention relates to oligomers, polymers and lipidoids comprising characteristic oligo(alkylene amine) moieties which are useful as vehicles for transfecting a cell with RNA. The present invention furthermore relates to a composition comprising at least a nucleic acid and an oligomer or polymer or a lipidoid comprising such oligo(alkylene amine) moieties and to a method of transfecting a cell using said composition. Furthermore, the present invention relates to pharmaceutical compositions and uses.

Abstract: The present invention includes an apparatus for determining and/or monitoring a process variable, especially the temperature, or the flow, of a medium in a containment, including a temperature sensor for registering temperature and a flexible, a heat insulating support element, which is arrangeable on an outer surface of a wall of the containment, wherein the temperature sensor is secured to the support element.

Abstract: The present invention relates to a coating composition comprising a solid component comprising a clay and mica, wherein the clay comprises from about 50 to about 90% by weight of kaolinite and from about 5 to about 35% by weight of montmorillonite and the coating composition comprises, based on the solid component, from about 5 to about 50 parts by weight of clay. Furthermore, a process for coating a casting mold and the use of the coating composition for coating a casting mold are disclosed.

Abstract: Improved spherical beads that may be used in producing pharmaceutically active pellets by depositing a pharmaceutically active agent on the surface of said spherical beads. The spherical beads includes a pharmaceutically acceptable carrier material, including: a) at least 60 wt. % of phosphoric acid calcium salt and b) up to 40 wt. % of organic material. Greater than or equal to 90 wt % of the spherical beads have a particle size in the range of from 90 ?m to 1200 ?m. The spherical beads have: a bulk density of at least or more than 1000 g/l, a specific surface area of at most or less than 10 m2/g, and a hardness of at least or more than 600 g/mm2. Also included is a method for producing such spherical beads and to pharmaceutically active pellets being prepared by depositing a pharmaceutically active agent on the surface of the spherical beads.

Abstract: The present invention relates to oligomers, polymers and lipidoids comprising characteristic oligo(alkylene amine) moieties which are useful as vehicles for transfecting a cell with RNA. The present invention furthermore relates to a composition comprising at least a nucleic acid and an oligomer or polymer or a lipidoid comprising such oligo(alkylene amine) moieties and to a method of transfecting a cell using said composition. Furthermore, the present invention relates to pharmaceutical compositions and uses.

Abstract: A luminophore having the general empirical formula X?1-xA?y(Al1+zA?3-z)O4:E? that crystallizes in a tetragonal crystal system. X? may be Mg, Ca, Sr, Ba, and combinations thereof; A? may be Li, Na, K, Rb, Cs, and combinations thereof; E? may be Eu, Ce, Yb, Mn, and combinations thereof; 0<x<0.25; y?x; andz = 0.5 ( 2 ? x - y ) .

Abstract: A luminophore having the general empirical formula X?1?xA?y(Al1+zA?3?z)O4:E? that crystallizes in a tetragonal crystal system. X? may be Mg, Ca, Sr, Ba, and combinations thereof; A? may be Li, Na, K, Rb, Cs, and combinations thereof; E? may be Eu, Ce, Yb, Mn, and combinations thereof; 0<x<0.25; y?x; and z=0.5(2x?y).

Abstract: A phosphor may have the general formula EA2A4D3OxN8-x:RE. EA may be selected from the group of divalent elements. A may be selected from the group of monovalent, divalent or trivalent elements. D may be selected from the group of trivalent or tetravalent elements. RE may be an activator element. 0?x?8, and ?(4+4y+3z)=3(8?x)+2x with the charge number y of element A, the charge number z of element D, and ?=0.9-1.1.

Abstract: A luminophore having the general empirical formula X?1?xA?y(Al1+zA?3?z) O4:E? that crystallizes in a tetragonal crystal system. X? may be Mg, Ca, Sr, Ba, and combinations thereof; A? may be Li, Na, K, Rb, Cs, and combinations thereof; E? may be Eu, Ce, Yb, Mn, and combinations thereof; 0<x<0.25; y?x; and z=0.5(2x?y).

Abstract: A phosphor may have the general formula EA2A4D3OxN8-x:RE. EA may be selected from the group of divalent elements. A may be selected from the group of monovalent, divalent or trivalent elements. D may be selected from the group of trivalent or tetravalent elements. RE may be an activator element. 0?x?8, and ?(4+4y+3z)=3(8?x)+2x with the charge number y of element A, the charge number z of element D, and ?=0.9-1.1.

Abstract: A sanitary fitting (1) containing an outer housing (2) having a sensor (3), wherein the sensor (3) contains at least a first electrical connector (4), and an inner housing (5) to which a connector assembly (11) having at least one second electrical connector (6) is attached in a detachable manner, wherein the inner housing (5) can be disposed in the outer housing (2) in such a way that the at least one first electrical connector (4) and the at least one second electrical connector (6) form a first electrical plug connection (7).

Abstract: A luminophore may have the general empirical formula X3A7Z3O11:E, where: X=Mg, Ca, Sr, Ba, and/or Zn; A=Li, Na, K, Rb, Cs, Cu, and/or Ag; Z=Al, Ga, and/or B; and E=Eu, Ce, Yb, and/or Mn.

Abstract: Improved spherical beads that may be used in producing pharmaceutically active pellets by depositing a pharmaceutically active agent on the surface of said spherical beads. The spherical beads includes a pharmaceutically acceptable carrier material, including: a) at least 60 wt. % of phosphoric acid calcium salt and b) up to 40 wt. % of organic material. Greater than or equal to 90 wt % of the spherical beads have a particle size in the range of from 90 ?m to 1200 ?m. The spherical beads have: a bulk density of at least or more than 1000 g/l, a specific surface area of at most or less than 10 m2/g, and a hardness of at least or more than 600 g/mm2. Also included is a method for producing such spherical beads and to pharmaceutically active pellets being prepared by depositing a pharmaceutically active agent on the surface of the spherical beads.

Abstract: A display device for process automation includes a display unit, a controller, a current loop interface and a fieldbus interface. The display device is designed for power supply via the current loop interface, and the controller is designed to assign an analog coded signal of an output data present at the current loop interface to a first input data and to display the first input data via the display unit. The controller is designed to request the transmission of the output data in the form of a digitally coded signal via the fieldbus interface, to receive the digitally coded signal via the fieldbus interface, to assign the digitally coded signal to a second input data, to perform a comparison between the first input data and the second input data, and to display a result of the comparison via the display unit.

Abstract: The present invention relates to a coating composition comprising a solid component comprising a clay and mica, wherein the clay comprises from about 50 to about 90% by weight of kaolinite and from about 5 to about 35% by weight of montmorillonite and the coating composition comprises, based on the solid component, from about 5 to about 50 parts by weight of clay. Furthermore, a process for coating a casting mold and the use of the coating composition for coating a casting mold are disclosed.

Abstract: The disclosure provides a potassium aluminate phosphor which is doped with Mn+ or with Eu+ and Mn+, a lighting device, and methods for making the same. This disclosure also provides a conversion light emitting diode (LED) including a semiconductor layer sequence set up to emit electromagnetic primary radiation; and a conversion element including an Mn2+-doped potassium aluminate phosphor or an Eu2+- and Mn2+-doped potassium aluminate phosphor and at least partly converts the electromagnetic primary radiation to electromagnetic secondary radiation, wherein the Mn2+-doped potassium aluminate phosphor or the Eu2+- and Mn2+-doped potassium aluminate phosphor has a general empirical formula KxAl11+yO17+z:Mn2+, or KxAl11+yO17+z:(Mn2+,Eu2+).

Abstract: A luminophore may have the general empirical formula X3A7Z3O11:E, where: X=Mg, Ca, Sr, Ba, and/or Zn; A=Li, Na, K, Rb, Cs, Cu, and/or Ag; Z=Al, Ga, and/or B; and E=Eu, Ce, Yb, and/or Mn.